Skip to main content

MoneyWorks4Me

Lupin informs about press release

01 Feb 2022 Evaluate
Lupin has informed that it enclosed is a Press Release as regards the Company having entered into a License, Supply and Technology Sharing agreement with Axantia Holding, a leading pharmaceutical company in the region operating through its pharmaceutical subsidiaries; Pharma International Company and Med City Pharmaceutical Industries, for Pegfilgrastim in the Middle East and North Africa.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..